Suppr超能文献

两种氟尿嘧啶给药方案对结直肠癌的不同影响。

Differential effects of two fluorouracil administration regimens for colorectal cancer.

作者信息

Matsusaka Satoshi, Yamasaki Hajime, Kitayama Yoshihiro, Okada Toshihiro, Maeda Shigeto

机构信息

Department of Surgery, Sano Hospital, Shimizugaoka, Tarumi-ku, Kobe, Hyogo 655-0031, Japan.

出版信息

Oncol Rep. 2003 Jan-Feb;10(1):109-13.

Abstract

Mechanisms of anti-tumor action of 5-fluorouracil (5-FU) are presumed to inhibit DNA synthesis and RNA function, and the balance of these mechanisms is presumed to depend on the modalities of administration. On the other hand, variability of 5-FU sensitivity of the tumors is also presumed to depend on the enzymes of 5-FU metabolism (e.g. dihydropyrimidine dehydrogenase; DPD, rate limiting enzyme of catabolism) and action target (e.g. thymidylate synthase; TS). We studied the effects of modalities of administration and enzyme activities related to metabolism and target of 5-FU on the mechanism of anti-tumor action in patients with colorectal cancer. Thirty-eight patients who were diagnosed at stage II to IV preoperatively were enrolled. Patients were randomly assigned to receive 24-h protracted IV infusion of 5-FU at 320 mg/m(2)/day for 5 days (CIV group: 18 patients) or 10-min bolus IV infusion of 5-FU at the same dosage for 5 days (BIV group: 20 patients) administered from the 5th preoperative day. Specimens from the tumor and non-tumor regions were obtained by operation. F-RNA (fraudulent-RNA, or 5-FU in RNA) concentration, an indicator for action of 5-FU to RNA, and the enzyme activities of DPD and TS, an indicator for action of 5-FU to DNA, in the collected specimens were measured by GC-MS or RI-HPLC. F-RNA concentration (ng/mg-RNA) in the tumor and non-tumor region in the CIV group was 100.58+/-16.88 and 50.11+/-6.03, respectively, with a significant difference between them (P<0.05), and in the tumor and non-tumor region in the BIV group was 195.32+/-16.26 and 121.05+/-10.62, respectively, with a significant difference between them (P<0.01). F-RNA concentration in the tumor and non-tumor regions in the BIV group was significantly higher than those in the CIV group (P<0.05). DPD activity and TS activity were not significantly different between the CIV and the BIV groups in the tumor and non-tumor region, respectively. F-RNA concentration was negatively correlated to DPD activity (r=-0.540, P<0.05) in the tumor region in the CIV group. F-RNA was not correlated to DPD activity in the non-tumor region in the CIV group or in the tumor and non-tumor region in the BIV group. F-RNA was not correlated to TS activity in the tumor or non-tumor region of the two groups. DPD activity was not correlated to TS activity in the tumor or non-tumor region of the two groups. BIV inhibited RNA function more potently than CIV and this was not dependent on TS or DPD activity. As for the inhibition of DNA synthesis, other indicators should be considered further.

摘要

5-氟尿嘧啶(5-FU)的抗肿瘤作用机制据推测是抑制DNA合成和RNA功能,并且这些机制的平衡据推测取决于给药方式。另一方面,肿瘤对5-FU敏感性的变异性据推测也取决于5-FU代谢酶(如二氢嘧啶脱氢酶;DPD,分解代谢的限速酶)和作用靶点(如胸苷酸合成酶;TS)。我们研究了给药方式以及与5-FU代谢和靶点相关的酶活性对结直肠癌患者抗肿瘤作用机制的影响。纳入了38例术前诊断为II至IV期的患者。患者被随机分配,从术前第5天开始,接受5天的持续静脉输注5-FU,剂量为320mg/m²/天(持续静脉输注组:18例患者),或相同剂量的5-FU 10分钟静脉推注,持续5天(静脉推注组:20例患者)。通过手术获取肿瘤和非肿瘤区域的标本。通过气相色谱-质谱联用仪(GC-MS)或放射性免疫高效液相色谱法(RI-HPLC)测量收集标本中F-RNA(假RNA,即RNA中的5-FU)浓度,这是5-FU对RNA作用的指标,以及DPD和TS的酶活性,这是5-FU对DNA作用的指标。持续静脉输注组肿瘤和非肿瘤区域的F-RNA浓度(ng/mg-RNA)分别为100.58±16.88和50.11±6.03,两者之间有显著差异(P<0.05);静脉推注组肿瘤和非肿瘤区域的F-RNA浓度分别为195.32±16.26和121.05±10.62,两者之间有显著差异(P<0.01)。静脉推注组肿瘤和非肿瘤区域的F-RNA浓度显著高于持续静脉输注组(P<0.05)。持续静脉输注组和静脉推注组在肿瘤和非肿瘤区域的DPD活性和TS活性分别无显著差异。在持续静脉输注组的肿瘤区域,F-RNA浓度与DPD活性呈负相关(r=-0.540,P<0.05)。在持续静脉输注组的非肿瘤区域以及静脉推注组的肿瘤和非肿瘤区域,F-RNA与DPD活性均无相关性。在两组的肿瘤或非肿瘤区域,F-RNA与TS活性均无相关性。在两组的肿瘤或非肿瘤区域,DPD活性与TS活性均无相关性。静脉推注比持续静脉输注更有效地抑制RNA功能,但这并不依赖于TS或DPD活性。至于对DNA合成的抑制作用,应进一步考虑其他指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验